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• Nlld¢ Oxide Contributes to Bmdyklnln-lnduc~l 
Vmmdilatlon of Human Epio~rdlal Comnery 
Arlertes in r ive  
Mas~ya Kate, Nobue Shlnde, Masafumi Hir~gek Akit0 Hlmoka, 
Noboyuki Morishima, ShinJi Karakawa, Togo Yamagate, Hidoo Malsoura, 
Gore KaJiy~ma, First Department of Interest M~.~!~ine, Hireshima Univenz~y, 
HIroshimt~ J~u l  
It h~s been shown that 8radykinin induces endotheliurrH~fepondent mlax- 
a~an of isolated human coronary arteries in vitro, To investigate whether 
nltdc oxide (NO) release contributes to bmdykinln4nduced vasndtlation of 
human eplcardial coronary artedes In rive, we studied the alfe~ of inhi~i0n 
ot NO synthesis by Na-monometbyI.L*arginine (L-NMMA) on intxacomnary 
infusion of bradyklnln in 11 pa6ents wilh normal c~3mnmy a~fefiss. After I~se- 
line angiography, incremental doses of bradykiniil (0.5,1.5, and 2,5 p.g/min 
for 2 rain) were Infused into the left comnmy artery, After intmcomnary ad- 
ministration of L-i~ktMA (60 p~moVmln), repeat baseline angtngraphy was 
podormed. Then, incremental doses of bmoykinln were infused a~n,  fol- 
lowed by infusion of nitroglycerin (NTG, 200 pg). Changes i~ diameter of 
tie proximal and the distal left antedor descending and circumflex comnwy 
segments were measured by quantitative angtography, Pemant changes in 
coronary diameter were as follows (mean ~: 8D): 
B~'ad~,p_in (p~mln) . . . . . . . . . . . . . . . . . . . . . . . .  
0,5 1.5 2.S 
Proximal (n == 18) 
~fore L-NMMA +4 ~ 8%" +5 d: g%** +8 ~: 9%* 
Aller L.NM~A 0~4% +1 ~3% +2:1:4% 
~fore L~NMMA +7=E 7%* +12~ t3%* +13:E 1~J~* 
Alter L-NMMA -1 ~ 6% +2 d: 4% +2 ~ 6% 
*p < 0.01, ** p < 0.05 vS Baseline 
At baseline, L-NMMA reduced eptcartJial coronary diameters by 5 :E 9% 
and 5 ± 10% in the proximal and the distal coronary segments, respectively, 
Although bradykinin.i.du~d coronary vasedilation was observed before L* 
NMMA infusion in dose.dependom manner, il was reduced by L-NMMA. 
Endothelium*lndepandant dilation with NTG WaS significantly ot~,ewPd (p < 
0.01). Thus, brsdykinin.induced vasedilati0n o! human epicardial ot, lxmaw 
arteries is mediated by the action of endothelium.dedved NO in vivo, 
~ Role of Endothellum-Derived Nllrle Oxide in the 
Vesodllator Response to Mental Stress 
Carmine Cardilio, Crescen~e M. Ktlcoyne, Atshed A. Ouyyumi, Richmd 
O. Cannon til, Jutio A. Panza. NHLBI, Bethesda, MD 
End~thelium4erivnd itri~ oxide (NO) play~ a ~nkal role in reg~latir~l basal 
artedal tone, as well as in modulating vascular festivity to a variety of 
stimuli. The aim of this study was to determine whether endothelial NO m~,l' 
contribute to the vascular esponse to mental stress. To this purpose, we 
c~mpared the effect of saline and L-NMMA (4 t~moPmin for 15 rain), a blocker 
of NO synthesis, en forearm vascular dynamlce duflng mental adthmetic test 
(MAT) (repeated subtra~en of 7 from a thrse~git number for 3 mln) in 
15 normal subjects (9 males; age 44 :E 12 years) who unde~mt 2 tests 3 
hours apart. The effec~ of L.NMMA on endothelium-lndepandent vasedilatian 
was aludLad udng the Infusion of sodium flftroprusside (SNP) (0,4, 0.8 and 
1,S/~g/min) in 11 of the 15 subjects. Drugs were infused into the brachial 
artery and forsann vascular esponses were measured by plethysmography, 
L-NMMA did net modify mean artedal pressure and heart rote d~dng MAT 
(98,7 :E 11.3 vs. 98.1 :E 10.1 mmHg, and 7S,9 :E 12,8 vs, 7S.9 ~: ~5 bpm, 
respectively; both p = NS). Basal blood flow w~ siOniticantiy lower dudng 
L*NMMA than during saline (1.66 + 0.62 vs, 2.14 + 0,69 mUmi~/100 mL; 
p <: 0,0t). L*NMMA significantly blunted the increase in blond tiow induced 
by MAT (from 116 d: 70% to 38 ± 16%, p < 0,001), but did net modify the 
maximum flow increase induced by SNP (173 • ?1% during saline vs. 232 
~: 89% during L-NMMA; p = NS). These findings indicate that endothelial 
release of NO plays a role in the va~dilatar response to mental stress, This. 
may help explain the a~nonnal vascular msponsivenass ,~~ is stimulus in 
conditions associated with impaired endothelial vl~xlilatsr function. 
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Acute AntHechemlc Effect of Estmdlo117/3 in 
.......... ~enopauesl Woman With Coronary Artery Disease 
GIuseppe M,C. Rosario, Addano Mandes C~ixets. Stguem;luzo Arie, Miguel 
Lopoz H~,  W~/ner I. Pemira, Rlippo Leonardo, Peter Collins, 
Futvio PJlSggi, IM/hAO do Coracao, See Paulo, Brazil; National Heart & Lung 
Institute, london, United Kingdom 
Prsvious StudieS have suggested that estmdiol 17~ improves effort-induced 
myocardial isohemla in female pts w~ coronary artery disease (CAD), Re- 
cent studieS, however, have questioned this after. Aim of the present study 
was to evaluate the effect of acute adminislratlen of estradiel 17~ upon 
pa¢tng-iedt~.~cl myocan~ial isohem[a by means Of Continuou~ monitoring of 
seronary sinus pH in 16 female menopausal pts with CAD. Pts underwent 
in~rsmsn~ atrial pacing starting at e rate of 100 bpm and increments of 20 
10pro ~w~ty 2 n,ln up to 160 bpm before and 15 min after either eStmdio117~ 
(1 ~ sublingual, 9 I:~) or placebo (subli~lual. 7 pts). The time o! onset of 
myo~adial ischemia during pacing was significantly increased W estradiol 
17/~ (254 • 38 vs 298 :E 23 sect p < 0,01) but not by p ~  (262 =E 4S vs 
256 ~ 34 sect p -~ NS) The pH sP~; was signlf'¢an~ re,'Juoed by estra~ol 
17p but not by pte0~o ~t every step of the pacing protoeet. The maximum 
pH shift at ~ paring was signireantiy reduced by the adminislration of 
eStmdio117.8 bj 0,G22 pH Units (95% C.L 0.001, 0.043; p < 0.04) but not by 
sublinguel p la~o (-0.002 pH Units, 95% C.I. -0.01)73. 0~0021; p = NS). 
The rn~ximum pH shift at maximum comparable pacing was also reduced by 
astn~dio117# by0.015 (95% C.I. 0.012. 0.017; p < 0.001) but not by placebo 
-0.~2~ (95% O,I. -0.006, 0,001St p = NS). The reduction of pacing4nduced 
eomnary sinus pH shift are consistent with an antHschomic effect of the hor- 
mone and am not due to precoeditJoning as suggested by the absnoce of 
improvemer~ after placebo. In con~usion estmdiol 17p reduces the degree 
of pacir~inducad myocaldial ischemia in menopausal pta with GAD. 
Efficacy and Safety of Once.Daily Monotherapy 
............ With Coat.Corn Nlsoldiplne in Patients With Stable 
Angina Pectods: Dose Response Studies 
Udho Thadani, for the Nisotcl~ne Study Group. University of Oklahoma 
HSC, Oklahoma Cit~. OK 
NiSoldiplne (ffiS) is a potent dthydmpyfidine ¢~d~um channel blocker but 
the stsrclard farmulation requires multiple dmly dosing for optimal efficacy 
and r~ay occasionally ¢~oduce proischgm~c eftac~. We therefore evaluated 
• e safety and alficacy of an extended release formulation (Coat Core) of 
NIS, i~t 2TI patients with reproducible xercise (EX) induced angina. After 
therapy with single.blind placebo for 2 weeks, patients were randomized in 
a doubls.bS~ manner to once daily therapy with ether placebo (PLA), or 
NIS 10, NIS 20 or NIS 30 rag. Symptom limited F.X tests we~ mpe~ted after 
2 weeks of therspy at 4-8 hours (peak) end 24 hours (trough) post dose. 
Ohang~ in seconds from baseflne (single-blind placebo) F.,X variables were: 
PLA NIS OD 
remg ;~0 mg 30rag 
l"ir~ to EX Tefff~na~n (n=62)  (n-S4) in," 58l (n=61) 
Peak 27 53" 75" 63" 
Trough ~ 34 53 SS "÷ 
1~me tQ 1 mmSTT (n = 44) (n- 43) (n* 40) (n- 42) 
Pe~k 37 47 56 57 
Trough 9 30 49 7'1 *+ 
*p < 0.(15 vS PI~; +p < 0.05 vs 10 mg NF~ 
Goat Core Nl~t was well tolerated without proisohemtc effects and the most 
frsqusn~ ~rr ing  ~-~,~e vents were pedpheral edema and headache. 
Rasu~ show th~ ~'¢e daily therapy with NI$10, 20 and 30 mg ircmased 
EX time at ~ hours post dose and the 30 mg dose increased EX time and 
time tO ischecnta 24 hours post close. Thus in patients with exectse induced 
engine pactods monotherapy wiff130 mg NIS Coat Core once a day is safe 
elfecttvs throughout the dosing i.te~d. 
